Literature DB >> 7834204

Block of the delayed rectifier current (IK) by the 5-HT3 antagonists ondansetron and granisetron in feline ventricular myocytes.

F G de Lorenzi1, T R Bridal, W Spinelli.   

Abstract

1. We investigated the effects of two 5-HT3 antagonists, ondansetron and granisetron, on the action potential duration (APD) and the delayed rectifier current (IK) of feline isolated ventricular myocytes. Whole-cell current and action potential recordings were performed at 37 degrees C with the patch clamp technique. 2. Ondansetron and granisetron blocked IK with a KD of 1.7 +/- 1.0 and 4.3 +/- 1.7 microM, respectively. At a higher concentration (30 microM), both drugs blocked the inward rectifier (IKl). 3. The block of IK was dependent on channel activation. Both drugs slowed the decay of IK tail currents and produced a crossover with the pre-drug current trace. These results are consistent with block and unblock from the open state of the channel. 4. Granisetron showed an intrinsic voltage-dependence as the block increased with depolarization. The equivalent voltage-dependency of block (delta) was 0.10 +/- 0.04, suggesting that granisetron blocks from the intracellular side at a binding site located 10% across the transmembrane electrical field. 5. Ondansetron (1 microM) and granisetron (3 microM) prolonged APD by about 30% at 0.5 Hz. The prolongation of APD by ondansetron was abolished at faster frequencies (3 Hz) showing reverse rate dependence. 6. In conclusion, the 5-HT3 antagonists, ondansetron and granisetron, are open state blockers of the ventricular delayed rectifier and show a clear class III action.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7834204      PMCID: PMC1510143          DOI: 10.1111/j.1476-5381.1994.tb17021.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  5-Hydroxytryptamine antagonist ICS 205-930 blocks cardiac potassium, sodium and calcium currents.

Authors:  G Scholtysik; Y Imoto; A Yatani; A M Brown
Journal:  J Pharmacol Exp Ther       Date:  1988-06       Impact factor: 4.030

2.  Evidence for inhibition by ICS 205-930 and stimulation by BRL 34915 of K+ conductance in cardiac muscle.

Authors:  G Scholtysik
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-06       Impact factor: 3.000

3.  Antiarrhythmic effect of a 5-hydroxytryptamine M-receptor antagonist, ICS 205-930.

Authors:  J Morganroth; C McGinn
Journal:  Am J Cardiol       Date:  1988-02-15       Impact factor: 2.778

4.  Outward membrane currents activated in the plateau range of potentials in cardiac Purkinje fibres.

Authors:  D Noble; R W Tsien
Journal:  J Physiol       Date:  1969-01       Impact factor: 5.182

5.  Comparison of potassium currents in rabbit atrial and ventricular cells.

Authors:  W R Giles; Y Imaizumi
Journal:  J Physiol       Date:  1988-11       Impact factor: 5.182

6.  Cellular electrophysiology of WAY-123,398, a new class III antiarrhythmic agent: specificity of IK block and lack of reverse use dependence in cat ventricular myocytes.

Authors:  W Spinelli; I F Moubarak; R W Parsons; T J Colatsky
Journal:  Cardiovasc Res       Date:  1993-09       Impact factor: 10.787

7.  Isolation and morphology of calcium-tolerant feline ventricular myocytes.

Authors:  L H Silver; E L Hemwall; T A Marino; S R Houser
Journal:  Am J Physiol       Date:  1983-11

8.  Antiarrhythmic and electrophysiological effects of ICS 205-930, an antagonist of 5-hydroxytryptamine at peripheral receptors.

Authors:  F M Williams; A L Rothaul; K A Kane; J R Parratt
Journal:  J Cardiovasc Pharmacol       Date:  1985 May-Jun       Impact factor: 3.105

9.  The effects of ICS 205-930, a 5-HT antagonist, on arrhythmias and catecholamine release during canine myocardial ischaemia and reperfusion.

Authors:  S J Coker; H G Dean; K A Kane; J R Parratt
Journal:  Eur J Pharmacol       Date:  1986-08-15       Impact factor: 4.432

10.  Ionic blockage of sodium channels in nerve.

Authors:  A M Woodhull
Journal:  J Gen Physiol       Date:  1973-06       Impact factor: 4.086

View more
  4 in total

1.  Ondansetron and granisetron binding orientation in the 5-HT(3) receptor determined by unnatural amino acid mutagenesis.

Authors:  Noah H Duffy; Henry A Lester; Dennis A Dougherty
Journal:  ACS Chem Biol       Date:  2012-08-15       Impact factor: 5.100

2.  Ondansetron blocks wild-type and p.F503L variant small-conductance Ca2+-activated K+ channels.

Authors:  Jum-Suk Ko; Shuai Guo; Jonathan Hassel; Patricia Celestino-Soper; Ty C Lynnes; James E Tisdale; James J Zheng; Stanley E Taylor; Tatiana Foroud; Michael D Murray; Richard J Kovacs; Xiaochun Li; Shien-Fong Lin; Zhenhui Chen; Matteo Vatta; Peng-Sheng Chen; Michael Rubart
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-04-20       Impact factor: 4.733

3.  Serotonin and protein kinase C modulation of a rat brain inwardly rectifying K+ channel expressed in xenopus oocytes.

Authors:  L DiMagno; N Dascal; N Davidson; H A Lester; W Schreibmayer
Journal:  Pflugers Arch       Date:  1996-01       Impact factor: 3.657

4.  Drug utilization in emergency medicine department at a tertiary care teaching hospital: A prospective study.

Authors:  Preksha A Barot; Supriya D Malhotra; Devang A Rana; Varsha J Patel; Kamlesh P Patel
Journal:  J Basic Clin Pharm       Date:  2013-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.